Nwk Group, Inc. Abbott Laboratories Transaction History

Nwk Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $692,924 - $815,671	-6,550 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $17,087 - $20,132	-157 Reduced 2.34%	6,550 $785,000
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $2,730 - $2,974	26 Added 0.39%	6,707 $734,000
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $18,053 - $21,924	197 Added 3.04%	6,681 $727,000
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $1,990 - $2,548	26 Added 0.4%	6,484 $593,000
Q1 2020 May 12, 2020	BUY	$62.82 - $91.86 $37,692 - $55,116	600 Added 10.24%	6,458 $510,000
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $459,911 - $511,989	5,858 New	5,858 $509,000

3,138

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nwk Group, Inc. with notifications on news.